Radiation and eye injections tested to save vision from rare eye cancer
NCT ID NCT03712904
Summary
This study tested a two-part treatment for a rare eye cancer called uveal melanoma. It combined precise radiation therapy with injections of a drug (aflibercept) into the eye. The goal was to see if this approach could control the tumor while better preserving the patient's vision by reducing side effects from the radiation. The trial was stopped early after enrolling only 3 patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UVEAL MELANOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Sidney Kimmel Cancer Center at Thomas Jefferson University
Philadelphia, Pennsylvania, 19107, United States
Conditions
Explore the condition pages connected to this study.